ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
GT Biopharma Inc

GT Biopharma Inc (GTBP)

3.0548
0.2548
( 9.10% )
Updated: 08:56:43

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 21.07M16.74M20.09M18.14M16.15M14.11M9.91M9.27M
Total Current Assets 20.87M16.56M19.94M18.02M16.05M14.06M9.89M9.27M
Cash and Equivalents 2.47M5.67M2.05M2.77M2.65M1.08M1.95M9.25M
Total Non-Current Assets 199k174k149k123k96k53k27k0
Total Liabilities 5.12M5M7.03M6.38M6.14M6.63M4.6M3.76M
Total Current Liabilities 5.03M4.94M4.08M4.84M5.09M6.63M4.6M3.76M
Total Non-Current Liabilities 92k64k2.96M1.54M1.05M000
Common Equity 34k34k38k42k43k2k2k3k
Retained Earnings -668.88M-674.47M-674.7M-676.69M-679.1M-682.07M-684.33M-688.04M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 25k254.37M25.4M396k5.66M32.17M16.74M14.11M
Total Current Assets 21k576k90k274k5.66M32.17M16.56M14.06M
Cash and Equivalents 19k576k60k28k5.3M8.97M5.67M1.08M
Total Non-Current Assets -18.92M251.69M11.37M-19.31M-29.43M21.91M11.73M7.48M
Total Liabilities 18.95M2.68M14.03M19.71M35.09M10.26M5M6.63M
Total Current Liabilities 18.95M2.68M14.03M19.71M35.09M10.26M4.94M6.63M
Total Non-Current Liabilities 00000064k0
Total Equity -18.92M251.69M11.37M-19.31M-29.43M21.91M11.73M7.48M
Common Equity 34k52k53k73k55k33k34k2k
Retained Earnings -124.65M-267.9M-528.69M-567.33M-595.63M-653.58M-674.47M-682.07M